Latest News

 Filter by Provider

Prediction: Nvidia stock's post-earnings-release move will largely hinge on news about the H20 chip for China and related Q3 guidance.

As the market reaches new all-time highs, these stocks are left behind due to popularity factors and not true fundamentals, creating an opportunity. 

Interactive Brokers Group Inc (NASDAQ:IBKR) shares are trading higher in Monday's after-hours session after it was announced the company will join the S&P 500.

The oil markets had a mixed day today.

Today was a particularly wild ride for the meme stock.

The Dow traded in last week's record for a triple-digit drop on Monday, while the tech-heavy Nasdaq failed to maintain its midday comeback.

Nvidia (NASDAQ: NVDA) is a major influencer of tech- and semiconductor-oriented ETFs, with a 22% weight in VanEck Semiconductor ETF and significant holdings in other funds. Its earnings can impact the performance of these ETFs, with three potential scenarios: a beat with strong guidance, in-line results, or weak performance. Suppliers and component companies may also be affected. September's earnings should provide clarity on hyperscaler spending, product roadmap, export control, and China revenue.

The stock market finished the day mostly lower, although the S&P 500 was relatively unchanged, down just 43 bps, with most of it coming in the final minutes of the day.

Investors clearly found the taste of the beverage conglomerate's latest deal sour.

Defense contractor Heico topped estimates for third-quarter results. Shares hit a record high earlier this month.

The company announced a flotation of its common shares that is potentially quite dilutive.

Nvidia has been on another incredible run over the past four months, rising some 85% from April lows to about $180 per share.

Kevin O'Leary is known for investing in companies and assets like watches and wine. Here's why the "Shark Tank" host is investing in trading cards, including a record breaker.

Lower interest rates and aggressive monetary growth will slam the dollar. Higher rates and restrictive monetary policy will depress economic activity. Tariffs magnify labor market risks.

Figma Inc (NYSE:FIG) shares faced heavy selling pressure during regular trading hours on Monday after several analyst firms initiated coverage on the stock. Here's what you need to know.

AvidBank Holdings (AVBH) reported strong Q2 2025 results, beating EPS and revenue estimates. The bank showed robust loan growth and improved net interest income, despite a cautious market reaction.

After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Nearly three years after the launch of ChatGPT, most investors view MSFT as the winner relative to GOOGL, if for no other reason than its investments in OpenAI that have given it a 49% share of the company’s future profits.

Aerospace and defense company HEICO (NSYE:HEI) announced better-than-expected revenue in Q2 CY2025, with sales up 15.7% year on year to $1.15 billion. Its GAAP profit of $1.26 per share was 10.3% above analysts’ consensus estimates.

Trump wants the Fed to control more than it can.

U.S. banks argue the current regulation gives crypto exchanges an unfair yield advantage.

Apple's streaming pricing update could be part of the company's plan to grow services and subscription revenue.

Shares of Etsy closed sharply lower Monday. Investors are reacting to widespread disruptions in international shipping.

Gasoline prices have slipped noticeably this year, tracking the broader decline in crude oil.

Semtech (SMTC) Q2 FY2026 earnings: Revenue beats estimates with $257.6M, up 19.6% YoY. Non-GAAP EPS of $0.41 meets expectations.

Fundstrat Capital is launching new ETFs for small- & mid-cap stocks and large-cap stocks with income strategy. Their first ETF has seen huge success.

Retail traders expand the recent "meme stock" surge that began with Opendoor to two new targets: Offerpad and Inno.

Sprouts Farmers Market management is buying back $1 billion worth of stock, signaling new potential upside could be underway in the company.

HCW Biologics Inc. (NASDAQ: HCWB) shares were up Monday after the company announced a breakthrough in developing second-generation pembrolizumab-based immunotherapies for solid tumors.

The lawsuit alleges Apple’s App Store rankings unfairly favour ChatGPT while deprioritising rivals like Grok, which the billionaire claims is an “unequivocal antitrust violation”.